Specialty Pharmaceuticals from Cardinal Health 105, LLC

The state of New York has issued a sole-source contract opportunity for Specialty Pharmaceuticals through Cardinal Health 105, LLC, which has been granted an exemption from standard advertising requirements by the Office of the State Comptroller (OSC). This procurement covers pharmaceutical products and will be applicable across all New York State counties, with a contract term spanning from June 1, 2025, to May 31, 2030. The contract represents a direct award to Cardinal Health 105, LLC, indicating a unique capability or exclusive provider status for the specified pharmaceutical offerings. The solicitation was posted on June 2, 2025, with an advertisement end date of June 9, 2025, providing a limited window for potential inquiries or comments. Interested parties are directed to contact the specific contracting agency for any questions regarding this sole-source procurement, which appears to be centered on specialized pharmaceutical supply and distribution.

While the documentation does not explicitly detail set-aside designations or specific vendor restrictions, the sole-source nature of the contract suggests Cardinal Health 105, LLC is the exclusive or preferred vendor for these specialty pharmaceutical products. The contract covers all New York State counties, implying a comprehensive statewide distribution strategy. The procurement mechanism appears to be based on unique vendor qualifications or exclusive product capabilities that warrant a direct award without competitive bidding. No specific budget range or award value is disclosed in the available documentation. The five-year contract duration indicates a significant, long-term commitment to the pharmaceutical supply arrangement with Cardinal Health 105, LLC, suggesting a strategic and potentially mission-critical procurement for the state's healthcare infrastructure.